食管切除术切缘处理实践与生存影响分析
本研究通过调查胸外科医生对食管切除术中切缘阳性的处理方式,并回顾两家高容量食管癌中心1994至2017年94例术中切缘阳性患者数据。发现85%的医生使用术中冰冻切片指导再切除,再切除后46.8%转为R0切除,R0组总生存(13个月)和无进展生存(8.6个月)均优于R+组,切缘状态是无进展生存的独立预测因子。
要点
- 85%胸外科医生使用术中冰冻切片评估切缘并尝试再切除。
- 术中切缘阳性再切除后46.8%转为R0切除。
- R0切除者总生存和无进展生存均显著优于R+者。
核心结论
- 食管切除术中切缘阳性患者若可再切除至阴性切缘,无进展生存改善。
- 最终切缘状态与无进展生存相关,且为独立预测因子。
研究设计与样本
- 对胸外科医生的问卷调查,了解术中切缘阳性处理方式。
- 回顾性分析两家高容量食管癌中心1994至2017年94例术中冰冻切缘阳性患者。
- 采用Cox模型评估总生存和无进展生存。
主要发现
- 85%的受访胸外科医生报告术中使用冰冻病理评估并尝试再切除以达到阴性切缘。
- 94例术中切缘阳性患者中,67例(63%)接受再切除,其中44例(46.8%)转为R0切除。
- R0组总生存13个月 vs R+组3.4个月(P = .04)。
- R0组无进展生存8.6个月 vs R+组2.2个月(P = .03)。
- 多变量分析中,切缘状态是无进展生存的独立预测因子(风险比3.13,P = .03)。
临床怎么用
- 食管切除术中可考虑使用冰冻切片评估切缘,对阳性切缘尝试再切除以争取R0。
- 最终切缘状态可用于预后评估,阴性切缘与更好的无进展生存相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to determine how thoracic surgeons manage intraoperative esophagectomy positive margins and how these decisions may relate to overall survival and progression-free survival in esophageal cancer. METHODS: A survey was sent to thoracic surgeons to understand the management of intraoperative positive esophagectomy margins. Primary data at two high-volume esophageal cancer institutions from 1994 to 2017 were retrospectively reviewed to identify patients who had intraoperative positive frozen section margins during esophagectomy. Patient characteristics and survival data were collected and analyzed. Overall survival and progression-free survival were assessed using a Cox model. RESULTS: Eighty-five percent of thoracic surgeons responding to a survey reported the utilization of frozen pathologic evaluation during esophagectomy with attempts at re-resection to achieve negative margin. Our esophagectomy database identified 94 patients with intraoperative positive margins. Of those re-resected (n = 67, 63%), 44 patients (46.8%) were converted to R0 resections. overall survival was improved for patients in the R0 group (13 months) vs R+ group (3.4 months, P = .04). Progression-free survival was also improved between the R0 group (8.6 months) and the R+ group (2.2 months, P = .03). In a multivariable analysis for progression-free survival, margin status was an independent predictor of survival (hazard ratio 3.13, P = .03). CONCLUSIONS: From a thoracic surgery survey, 85% of surgeons use intraoperative frozen section margin analysis to guide surgical decision making during an esophagectomy. Analyzing patients with a positive margin discovered during esophagectomy suggests that esophageal cancer patients who can undergo re-resection to a negative margin have increased progression-free survival. The final margin appears to be related to progression-free survival.
引用
- Saddoughi SA, Mitchell KG, Antonoff MB, et al. Analysis of Esophagectomy Margin Practice and Survival Implications. Ann Thorac Surg. 2021. PMID: 33524359. doi:10.1016/j.athoracsur.2021.01.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。